Levette 0.15mg. 0.03mg Tablets
PDF Leaflet Revision Date: July 2015
Clinical Summary
Quick overview from the medicine insert
Indication
Oral contraception and control of dysfunctional uterine bleeding.
Dosage (summary)
One tablet daily for 28 days, starting on day 1 of the menstrual cycle.
Special Populations
- Obesity
- Hypertension
- Migraine
Pregnancy & Breastfeeding
Contraindicated in pregnancy; not recommended during lactation.
Key Drug Interactions
- Antibiotics
- Antiepileptics
- St. John's Wort
Contraindications
- Venous/arterial thrombosis
- Severe hepatic disease
- Pregnancy
Common side effects
- Nausea
- Headache
- Mood swings
- Breast tenderness
Counselling Points
- Take at the same time daily
- Use additional contraception if missed doses
- Monitor for signs of thrombosis
Serious warnings
- Increased risk of thromboembolism
- Cervical cancer risk
- Breast cancer risk
Important Disclaimer
The Levette 0.15mg. 0.03mg Tablets professional information leaflet below is the property of Actor Pharma and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
